A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer patients

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.

If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.